Z 2931
Pill imprint Z 2931 has been identified as Methyldopa 250 mg.
Methyldopa is used in the treatment of hypertensive emergency; high blood pressure and belongs to the drug class antiadrenergic agents, centrally acting. Risk cannot be ruled out during pregnancy.
Methyldopa 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Methyldopa Images
- Imprint:
-
Z 2931
- Strength:
- 250 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- citric acid
silicon dioxide colloidal
edetate disodium
ethylcellulose
hypromellose
magnesium stearate
methylcellulose
polyethylene glycol
sodium starch glycolate
titanium dioxide
calcium sulfate
hydroxypropyl cellulose
magnesium silicate
- Drug Class:
- Antiadrenergic agents, centrally acting
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- IVAX Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00172-2931
| NDC Code | Manufacturer / Repackager |
|---|---|
| 55887-0262 | Diversified Healthcare Services Inc (repackager) |
| 21695-0879 | Rebel Distributors Corp (repackager) |
| 54868-0050 | Physicians Total Care Inc (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Methyldopa resources
- Methyldopa (Wolters Kluwer)
- Methyldopate (Wolters Kluwer)
- methyldopa (Cerner Multum)
- methyldopa Oral, Intravenous (Micromedex) - Includes Dosage Information
- Methyldopa (AHFS DI)
- methyldopate hydrochloride (AHFS DI)
- Methyldopa (FDA)
- Methyldopate (FDA)
- Methyldopa and Methyldopate Hydrochloride (Wolters Kluwer)
Search Again
